Studies have shown that changes in tumor tissue immune status after radiotherapy are related to therapeutic effect, and patients with persistently high levels of PD-L1 and CD8+ tumor-infiltrating lymphocyte expression in tumor tissues before and after CRT have a poor prognosis (60). This evidence concerns the gene CD8A and neoplasm.